# A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

> **NCT04544787** · PHASE2 · COMPLETED · sponsor: **Pierre Van Damme** · enrollment: 250 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Novel OPV2 candidate 1
- **BIOLOGICAL:** Novel OPV2 candidate 2
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04544787
- **Lead sponsor:** Pierre Van Damme
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-22
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-05-08
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04544787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04544787, "A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04544787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*